期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

膜融合脂质体给药系统的研究进展 被引量：1

下载PDF
导出
摘要 膜融合脂质体是在传统脂质体基础上引入具有融合特性的病毒而形成的一种新的给药系统 ,它是介于病毒与非病毒性载体之间的杂合体 ,本文主要对膜融合脂质体给药系统的构建、特点。
作者 胡英 金山
机构地区 浙江大学药学院药剂学教研室
出处 《国外医学（药学分册）》 2004年第1期40-43,共4页 Foreign Medical Sciences(Section of Pharmarcy)
基金 国家自然科学基金资助项目 ( 93 0 0 70 896)
关键词 膜融合脂质体 基因治疗 仙台病毒
分类号 R94 [医药卫生—药剂学]
  • 相关文献

参考文献19

  • 1Harashima H, Shinohara Y, Kiwada H. Perspective of the new strategy of intracellular delivery of macromolecules with carrier[Jl. Drug Del Syst, 1999,14(1):157 - 164~.
  • 2Gabizon AA. Liposomal drug carrier systems in caner chemotherapy: current status and future prospects [ J]. J Drug Target, 2002, 10(7) :535 - 538.
  • 3Harashima H, Shinohara Y, Kiwada H. Intracellular control of gene trafficking using hposomes as drug carriers[ J]. Eur J Pharm Sci, 2001, 13(1):85-89.
  • 4Cho JE, Kim HS, Ahn WS. Enhanced cytotoxicity of doxorubicin encapsulated in liposomes with reconstituted Sendai F-proteins[J]. J Miroencapsul, 2001, 18(4) :421 - 431.
  • 5Kim HS, Park YS. Effect of lipid compositions on gene transfer into 293 cells using Sendai F/HN-virosomes[J]. J Biochem Mol Biol , 2002, 35(5):459-464.
  • 6Kim HS, Park YS. Gene transfection by quantitatively reconstituted Sendai envelop proteins into liposomes[J].Cancer Gene Ther, 2002, 9(2) : 173 - 177.
  • 7Takimoto T, Murti KG, Bonsse T, et al. Role of matrix and fusion proteins in budding of Sendai virus [ J ]. J Virol ,2001, 75(23) : 11384 - 11391 .
  • 8Mizuguchi H, Nakanishi T, Kondoh M, et al. Fusion of Sendai virus with liposome depends on only F protein, but not HN protein[J]. Virus Res, 1999:59(2):191-201.
  • 9Imazu S, Nakagawa S, Nakanishi T et al.A nowel nonviral vector based on vesicular stomtitis virus [J].J control Release, 2000, 68(2) : 187 - 194.
  • 10Takimoto T, Taylor GL, Crennell S J, et al. Crystallization of newcastle disease virus haemagglutinin-neuraminidase glycoprotein[J] . Virology, 2000, 270( 1 ):208 - 214.

同被引文献30

  • 1Maswadeh H, Demetzos C, Dimas K, et al. In vitro eytotoxic/cy'tostatic activity of anionic liposomes containing vinblastine against leukaemic human cell lines [J]. J Pharmacy and Pharmacology ,2002,54(2) : 189-196.
  • 2Paola C, Maurizio C, Paola B, et al. Preparation,characterization and property of sterically stabilized paclitaxelcontaining liposomes[J]. J Controlled Release, 2000,63:19-30.
  • 3Mei Z N, Chen H B, Weng T, et al. Solid lipid nanoparticles and microemulsion for topical delivery of triptolide[J]. Eur J Pharm Biopharm ,2003,56(2) : 189-196.
  • 4Yang S C, Lu L F, Cai Y, et al. Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain[J]. J Controlled Release, 1999, 59: 299-307.
  • 5Fenart L, CeccheUi R, Dehouck B, et al. In vitro model for evaluating drug transport across the blood-brain barrier[ J].Adv Drug Del Rev, 1999,36:165-178.
  • 6Radtke M, Mtiller R H. NLC-nanostructured lipid carrier: the new generation of lipid drug carriers[ J ]. New Drugs, 2001,2:48-52.
  • 7Olbrich C, Geβner A, Kayser O, et al. Lipid-drug conjugate(LDC) nanoparticles as novel earriersystem for hydrophilic anfitrypanosomal drug diminazenediaceturate [ J ]. J Drug Target, 2002, 10(5):387-396.
  • 8Wissing S A, Kayser O, Mtiller R H. Solid lipid nanoparticles for parenteral drug delivery[ J ]. Adv Drug Del Rev,2004, 56:1257-1272.
  • 9Jenning V, Thtinemannb A F, Gohla S H, et al. Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of fiquid and solid lipids[J], Inter J Pharm, 2000, 199:167-177.
  • 10Gessner A, Olbrieh C, Sehroder W, et al. The role of plasma proteins in brain targeting: speeiesdependem protein adsorption patterns on brainspecific lipid drug conjugate(LDC) nanoparticles[J]. Int J Pharm, 2001, 214(1-2):87-91.

引证文献1

二级引证文献2

国外医学（药学分册）
2004年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部